Buprenorphine in Tuvalu: not individually verified

What Tuvalu HAS confirmed for related substances

These are related compounds, not Buprenorphine. Their status may or may not reflect Buprenorphine’s. Confirm Buprenorphine directly with Tuvalu's national drug authority or your embassy.

• Codeinea related compound, not Buprenorphine

  Controlled in Tuvalu as a named dangerous drug under Part IV of the Dangerous Drugs Act. Codeine is entered by name at paragraph 1 of Part I of Schedule 2 to the Dangerous Drugs Act, Cap. 10.10, 2022 Revised Edition (page 32), and section 13(1) provides: “The provisions of this Part shall apply to the substances for the time being specified in Part I of Schedule 2.” Paragraph 3 adds “Any salt of a substance for the time being specified in paragraph 1 or 2 above”, paragraph 2 adds esters and ethers of a paragraph 1 substance, and paragraph 8 adds “Any preparation, admixture, extract or other substance containing any proportion of a substance for the time being specified in paragraph 1 above”. Codeine is also one of the substances to which Part II paragraph 9 applies, so low dose codeine preparations meeting that paragraph are excepted from the provisions listed in section 30, set out below. They are not described anywhere in the text as uncontrolled. The Dangerous Drugs (Amendment) Act 2025 (Act 9 of 2025) does not amend Schedule 2. The model is a schedule printed in the Act, with a power in section 13(2) for the Minister to modify Schedule 2 by order. No order is printed in the 2022 Revised Edition and none appears beneath the Act on the legislation site's index, as read on 7 October 2026. Raw opium, medicinal opium and prepared opium are separate entries and are outside this entry.

  Dangerous Drugs Act, Cap. 10.10, 2022 Revised Edition, sections 2, 5, 8, 13 to 16, 19, 20, 22, 25, 27, 30, 35, 39 and Schedule 2 Parts I and II (pages 32 to 35), read on 7 October 2026, sha256 c9e514235adcb847c794d886eb122ee2962045e6ea0e7c9ccaba18526a1cd53e · tuvalu-legislation.tv · Dangerous Drugs (Amendment) Act 2025, Act 9 of 2025, sections 1 to 6 and Schedule 3 (pages 5 to 9), read on 7 October 2026, sha256 36ac0ea5a9d1955f1967d00431c2a9e3cd94947e715f3881270ec4f2756863e6 · tuvalu-legislation.tv · Pharmacy and Therapeutic Products Act, Cap. 28.32, 2022 Revised Edition, sections 4, 9 and 42, read on 7 October 2026, sha256 625b92971e321cb4409bfbe2ce561a8674fa3a7e489afc00254a22e139dd3021 · tuvalu-legislation.tv · Customs Revenue and Border Protection Act 2014, Cap. 26.04, 2022 Revised Edition, sections 78, 212, 215, 216 and Schedule 2, printed pages 47, 108 to 110 and 145 to 147, read on 7 October 2026, sha256 b1747fd3511bcd3111d35f699933d9de68137065643d8bcf6f09d79b4778fbc0 · tuvalu-legislation.tv · Tuvalu Legislation On-line home page, read on 7 October 2026 · tuvalu-legislation.tv · Verified October 7, 2026

• Fentanyla related compound, not Buprenorphine

  Controlled in Tuvalu as a named dangerous drug under Part IV of the Dangerous Drugs Act, Cap. 10.10 (2022 Revised Edition), read with the Dangerous Drugs (Amendment) Act 2025 (Act 9 of 2025). Fentanyl is reached by name, not by a group or analogue clause. Section 13(1) (printed page 12) provides: “The provisions of this Part shall apply to the substances for the time being specified in Part I of Schedule 2.” Paragraph 1 of Part I of Schedule 2 (printed page 32) lists “Fentanyl.” Paragraph 2 reaches “Any ester (other than one expressly mentioned in paragraph 1 above) or ether (other than one so mentioned) of a substance for the time being specified in that paragraph”, paragraph 3 reaches any salt, and paragraph 8 reaches “Any preparation, admixture, extract or other substance containing any proportion of a substance” in paragraph 1 (printed page 34). Schedule 2 has no clause that controls fentanyl analogues as a group. A fentanyl derivative that is neither named in paragraph 1 nor an ester, ether or salt of a named substance is a scope boundary that the schedule text does not decide. None of the exceptions in Part II of Schedule 2 (paragraphs 9 to 14, printed pages 34 and 35) names fentanyl. Section 30 (printed page 16) provides: “The provisions of sections 14, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28 and 29 shall not apply to any preparation or other substance for the time being falling within Part II of Schedule 2.” Those sections include the section 14 import and export ban, the store rules and the section 20 possession offence, so a preparation that falls within Part II of Schedule 2 is outside them. Section 15 and new section 5(1) carry no matching exception. Section 2 defines “dangerous drug” as “any of the substances which may be from time to time subject to the provisions of this Act”, and section 13(2) lets the Minister modify Schedule 2 by order. No such order is in the text read. The schedule is printed in the Act and carries that delegated amendment power, so the entry is stated as at the 2022 Revised Edition and Act 9 of 2025.

  Dangerous Drugs Act, Cap. 10.10, 2022 Revised Edition, sections 2, 3, 13, 14, 15, 20, 22, 27, 30, 35 and 39 and Schedule 2 Parts I and II, printed pages 7 to 22 and 32 to 36, read on 7 October 2026 (pdftotext over the official PDF, sha256 c9e514235adcb847c794d886eb122ee2962045e6ea0e7c9ccaba18526a1cd53e) · tuvalu-legislation.tv · Dangerous Drugs (Amendment) Act 2025, Act 9 of 2025, sections 1, 3, 4 and 6 and Schedule 3, printed pages 5 to 9, read on 7 October 2026 (sha256 36ac0ea5a9d1955f1967d00431c2a9e3cd94947e715f3881270ec4f2756863e6) · tuvalu-legislation.tv · Pharmacy and Therapeutic Products Act, Cap. 28.32, 2022 Revised Edition, sections 9 and 42, printed pages 13 and 28, read on 7 October 2026 (sha256 625b92971e321cb4409bfbe2ce561a8674fa3a7e489afc00254a22e139dd3021) · tuvalu-legislation.tv · Customs Revenue and Border Protection Act 2014, Cap. 26.04, 2022 Revised Edition, sections 78, 212, 215 and 216 and Schedule 2 items 9 and 14, printed pages 47, 108 to 110 and 145 to 147, read on 7 October 2026 (sha256 b1747fd3511bcd3111d35f699933d9de68137065643d8bcf6f09d79b4778fbc0) · tuvalu-legislation.tv · Tuvalu Legislation On-line home page, read on 7 October 2026 · tuvalu-legislation.tv · Verified October 7, 2026

• Heroina related compound, not Buprenorphine

  Controlled in Tuvalu as a named dangerous drug under Part IV of the Dangerous Drugs Act, Cap. 10.10 (2022 Revised Edition), read with the Dangerous Drugs (Amendment) Act 2025 (Act 9 of 2025). Heroin is reached by name, not by a group or analogue clause. Section 13(1) (printed page 12) provides: “The provisions of this Part shall apply to the substances for the time being specified in Part I of Schedule 2.” Paragraph 1 of Part I of Schedule 2 (printed page 32) lists “Diamorphine.”, and section 2 (printed page 8) defines “diacetylmorphine” as “diacetylmorphine (diamorphine, heroin)”, which ties the printed name Diamorphine to the word heroin. Paragraph 3 reaches any salt of a listed substance, and paragraph 8 reaches “Any preparation, admixture, extract or other substance containing any proportion of a substance” in paragraph 1. The exceptions in Part II of Schedule 2 (paragraphs 9 to 14, printed pages 34 and 35) do not name diamorphine: paragraph 9 lists codeine and related substances, paragraph 10 cocaine, and paragraph 11 medicinal opium and morphine. Section 30 (printed page 16) provides: “The provisions of sections 14, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28 and 29 shall not apply to any preparation or other substance for the time being falling within Part II of Schedule 2.” Those sections include the section 14 import and export ban, the store rules and the section 20 possession offence, so a preparation that falls within Part II of Schedule 2 is outside them. Section 15 and new section 5(1) carry no matching exception. Section 2 defines “dangerous drug” as “any of the substances which may be from time to time subject to the provisions of this Act”, and section 13(2) lets the Minister modify Schedule 2 by order. No such order is in the text read. The schedule is printed in the Act and carries that delegated amendment power, so the entry is stated as at the 2022 Revised Edition and Act 9 of 2025.

  Dangerous Drugs Act, Cap. 10.10, 2022 Revised Edition, sections 2, 3, 13, 14, 15, 20, 22, 27, 30, 35 and 39 and Schedule 2 Parts I and II, printed pages 7 to 22 and 32 to 36, read on 7 October 2026 (pdftotext over the official PDF, sha256 c9e514235adcb847c794d886eb122ee2962045e6ea0e7c9ccaba18526a1cd53e) · tuvalu-legislation.tv · Dangerous Drugs (Amendment) Act 2025, Act 9 of 2025, sections 1, 3, 4 and 6 and Schedule 3, printed pages 5 to 9, read on 7 October 2026 (sha256 36ac0ea5a9d1955f1967d00431c2a9e3cd94947e715f3881270ec4f2756863e6) · tuvalu-legislation.tv · Pharmacy and Therapeutic Products Act, Cap. 28.32, 2022 Revised Edition, sections 9 and 42, printed pages 13 and 28, read on 7 October 2026 (sha256 625b92971e321cb4409bfbe2ce561a8674fa3a7e489afc00254a22e139dd3021) · tuvalu-legislation.tv · Customs Revenue and Border Protection Act 2014, Cap. 26.04, 2022 Revised Edition, sections 78, 212, 215 and 216 and Schedule 2 items 9 and 14, printed pages 47, 108 to 110 and 145 to 147, read on 7 October 2026 (sha256 b1747fd3511bcd3111d35f699933d9de68137065643d8bcf6f09d79b4778fbc0) · tuvalu-legislation.tv · Tuvalu Legislation On-line home page, read on 7 October 2026 · tuvalu-legislation.tv · Verified October 7, 2026

• Hydrocodonea related compound, not Buprenorphine

  Controlled in Tuvalu as a named dangerous drug under Part IV of the Dangerous Drugs Act. Hydrocodone is entered by name at paragraph 1 of Part I of Schedule 2 to the Dangerous Drugs Act, Cap. 10.10, 2022 Revised Edition (page 32), as “Hydrocodone (dihydrocodeinone).”, and section 13(1) provides: “The provisions of this Part shall apply to the substances for the time being specified in Part I of Schedule 2.” The print wraps the synonym across two lines. Paragraph 2 adds esters and ethers of a paragraph 1 substance, paragraph 3 adds “Any salt of a substance for the time being specified in paragraph 1 or 2 above”, and paragraph 8 adds “Any preparation, admixture, extract or other substance containing any proportion of a substance for the time being specified in paragraph 1 above”. Hydrocodone is not named in any paragraph of Part II of Schedule 2, the part that excepts certain preparations, and the dihydrocodeine that paragraph 9(2) does name is a different entry in paragraph 1 and not a synonym of this one, so no preparation exception is printed for hydrocodone. The Dangerous Drugs (Amendment) Act 2025 (Act 9 of 2025) does not amend Schedule 2. The model is a schedule printed in the Act, with a power in section 13(2) for the Minister to modify Schedule 2 by order. No order is printed in the 2022 Revised Edition and none appears beneath the Act on the legislation site's index, as read on 7 October 2026.

  Dangerous Drugs Act, Cap. 10.10, 2022 Revised Edition, sections 2, 5, 8, 13 to 16, 19, 20, 22, 25, 27, 30, 35, 39 and Schedule 2 Parts I and II (pages 32 to 35), read on 7 October 2026, sha256 c9e514235adcb847c794d886eb122ee2962045e6ea0e7c9ccaba18526a1cd53e · tuvalu-legislation.tv · Dangerous Drugs (Amendment) Act 2025, Act 9 of 2025, sections 1 to 6 and Schedule 3 (pages 5 to 9), read on 7 October 2026, sha256 36ac0ea5a9d1955f1967d00431c2a9e3cd94947e715f3881270ec4f2756863e6 · tuvalu-legislation.tv · Pharmacy and Therapeutic Products Act, Cap. 28.32, 2022 Revised Edition, sections 4, 9 and 42, read on 7 October 2026, sha256 625b92971e321cb4409bfbe2ce561a8674fa3a7e489afc00254a22e139dd3021 · tuvalu-legislation.tv · Customs Revenue and Border Protection Act 2014, Cap. 26.04, 2022 Revised Edition, sections 78, 212, 215, 216 and Schedule 2, printed pages 47, 108 to 110 and 145 to 147, read on 7 October 2026, sha256 b1747fd3511bcd3111d35f699933d9de68137065643d8bcf6f09d79b4778fbc0 · tuvalu-legislation.tv · Tuvalu Legislation On-line home page, read on 7 October 2026 · tuvalu-legislation.tv · Verified October 7, 2026

• Methadonea related compound, not Buprenorphine

  Controlled in Tuvalu as a named dangerous drug under Part IV of the Dangerous Drugs Act (Cap. 10.10, 2022 Revised Edition). Paragraph 1 of Part I of Schedule 2 lists “Methadone.” (page 33), and section 13(1) says “The provisions of this Part shall apply to the substances for the time being specified in Part I of Schedule 2”. Paragraph 3 adds “Any salt of a substance for the time being specified in paragraph 1 or 2 above” and paragraph 8 adds “Any preparation, admixture, extract or other substance containing any proportion of a substance for the time being specified in paragraph 1 above” (page 34). Methadone is not among the substances listed in paragraph 9(2) of Part II of Schedule 2, and paragraphs 10 to 14 of Part II concern cocaine, opium and morphine, diphenoxylate, ipecacuanha and opium powder, and mixtures of those preparations, so no Part II exception names it. Section 30 (printed page 16) provides: “The provisions of sections 14, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28 and 29 shall not apply to any preparation or other substance for the time being falling within Part II of Schedule 2.” Those sections include the section 14 import and export ban, the store rules and the section 20 possession offence, so a preparation that falls within Part II of Schedule 2 is outside them. Section 15 and new section 5(1) carry no matching exception. Isomethadone and Normethadone are separate entries in paragraph 1. Stated as at the 2022 Revised Edition as amended by the Dangerous Drugs (Amendment) Act 2025.

  Dangerous Drugs Act, Cap. 10.10, 2022 Revised Edition, sections 3, 13, 14, 15, 16, 19, 20, 22, 25, 27, 28, 30, 31, 35 and 39 and Schedule 2 Parts I and II, pages 10 to 22 and 32 to 35, read on 7 October 2026, sha256 c9e514235adcb847c794d886eb122ee2962045e6ea0e7c9ccaba18526a1cd53e · tuvalu-legislation.tv · Dangerous Drugs (Amendment) Act 2025, Act 9 of 2025, sections 1 to 6 and Schedule 3, pages 5 to 9, read on 7 October 2026, sha256 36ac0ea5a9d1955f1967d00431c2a9e3cd94947e715f3881270ec4f2756863e6 · tuvalu-legislation.tv · Customs Revenue and Border Protection Act 2014, Cap. 26.04, 2022 Revised Edition, sections 78, 212, 215 and 216 and Schedule 2 list of prohibited imports item 14 and list of restricted imports item 9, pages 47, 108 to 110 and 146 to 147, read on 7 October 2026, sha256 b1747fd3511bcd3111d35f699933d9de68137065643d8bcf6f09d79b4778fbc0 · tuvalu-legislation.tv · Pharmacy and Therapeutic Products Act, Cap. 28.32, 2022 Revised Edition, section 9 page 13 and section 42 page 28, read on 7 October 2026, sha256 625b92971e321cb4409bfbe2ce561a8674fa3a7e489afc00254a22e139dd3021 · tuvalu-legislation.tv · tuvalu-legislation.tv all-legislation index page, read on 7 October 2026, sha256 f1a30168fc3e2cb5944e6849a1de4afc5ceffddaa6b71bed2cf522c86d0c3070 · tuvalu-legislation.tv · Tuvalu Legislation On-line home page, read on 7 October 2026 · tuvalu-legislation.tv · Verified October 7, 2026

• Morphinea related compound, not Buprenorphine

  Controlled in Tuvalu as a named dangerous drug under Part IV of the Dangerous Drugs Act, Cap. 10.10 (2022 Revised Edition), read with the Dangerous Drugs (Amendment) Act 2025 (Act 9 of 2025). Morphine is reached by name, not by a group or analogue clause. Section 13(1) (printed page 12) provides: “The provisions of this Part shall apply to the substances for the time being specified in Part I of Schedule 2.” Paragraph 1 of Part I of Schedule 2 (printed page 33) lists “Morphine.”, together with morphine methobromide and other pentavalent nitrogen morphine derivatives, and the heading of Part IV itself names morphine alongside medicinal opium and cocaine. Paragraph 3 reaches any salt, and paragraph 8 reaches “Any preparation, admixture, extract or other substance containing any proportion of a substance” in paragraph 1 (printed page 34). One exception applies to morphine. Paragraph 11 of Part II of Schedule 2 (printed pages 34 and 35) reads “A preparation of medicinal opium or of morphine containing (in either case) not more than 0.2 per cent of morphine calculated as anhydrous morphine base, being a preparation compounded with 1 or more other ingredients in such a way that the preparation has no, or a negligible, risk of abuse and that the opium or, as the case may be, the morphine, cannot be recovered by readily applicable means or in a yield which would constitute a risk to health.” Section 30 (printed page 16) provides: “The provisions of sections 14, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28 and 29 shall not apply to any preparation or other substance for the time being falling within Part II of Schedule 2.” Those sections include the section 14 import and export ban, the store rules and the section 20 possession offence, so a preparation that falls within Part II of Schedule 2 is outside them. Section 15 and new section 5(1) carry no matching exception. Part II is headed as concerning preparations and other substances falling within Part I whose importation and exportation is excepted from control. The text read prints no exception from section 5(1) and section 15 for such a preparation. Morphine as the alkaloid is also a constituent of raw opium, which section 2 defines as the coagulated juice of the capsules “whatever its morphine content” and which Part II of the Act controls separately. Section 2 defines “dangerous drug” as “any of the substances which may be from time to time subject to the provisions of this Act”, and section 13(2) lets the Minister modify Schedule 2 by order. No such order is in the text read. The schedule is printed in the Act and carries that delegated amendment power, so the entry is stated as at the 2022 Revised Edition and Act 9 of 2025.

  Dangerous Drugs Act, Cap. 10.10, 2022 Revised Edition, sections 2, 3, 13, 14, 15, 16 to 19, 20, 22, 27, 30, 35 and 39 and Schedule 2 Parts I and II, printed pages 7 to 22 and 32 to 36, read on 7 October 2026 (pdftotext over the official PDF, sha256 c9e514235adcb847c794d886eb122ee2962045e6ea0e7c9ccaba18526a1cd53e) · tuvalu-legislation.tv · Dangerous Drugs (Amendment) Act 2025, Act 9 of 2025, sections 1, 3, 4 and 6 and Schedule 3, printed pages 5 to 9, read on 7 October 2026 (sha256 36ac0ea5a9d1955f1967d00431c2a9e3cd94947e715f3881270ec4f2756863e6) · tuvalu-legislation.tv · Pharmacy and Therapeutic Products Act, Cap. 28.32, 2022 Revised Edition, sections 9 and 42, printed pages 13 and 28, read on 7 October 2026 (sha256 625b92971e321cb4409bfbe2ce561a8674fa3a7e489afc00254a22e139dd3021) · tuvalu-legislation.tv · Customs Revenue and Border Protection Act 2014, Cap. 26.04, 2022 Revised Edition, sections 78, 212, 215 and 216 and Schedule 2 items 9 and 14, printed pages 47, 108 to 110 and 145 to 147, read on 7 October 2026 (sha256 b1747fd3511bcd3111d35f699933d9de68137065643d8bcf6f09d79b4778fbc0) · tuvalu-legislation.tv · Tuvalu Legislation On-line home page, read on 7 October 2026 · tuvalu-legislation.tv · Verified October 7, 2026

• Oxycodonea related compound, not Buprenorphine

  Controlled in Tuvalu as a named dangerous drug under Part IV of the Dangerous Drugs Act. Oxycodone is entered by name at paragraph 1 of Part I of Schedule 2 to the Dangerous Drugs Act, Cap. 10.10, 2022 Revised Edition (page 33), as “Oxycodone.”, and section 13(1) provides: “The provisions of this Part shall apply to the substances for the time being specified in Part I of Schedule 2.” Oxymorphone is a separate entry in the same list and is not the entry relied on here. Paragraph 2 adds esters and ethers of a paragraph 1 substance, paragraph 3 adds “Any salt of a substance for the time being specified in paragraph 1 or 2 above”, and paragraph 8 adds “Any preparation, admixture, extract or other substance containing any proportion of a substance for the time being specified in paragraph 1 above”. Oxycodone is not among the substances listed in Part II paragraph 9(2), and paragraphs 10 to 14 of Part II concern cocaine, opium and morphine preparations, diphenoxylate, a compound ipecacuanha and opium powder, and mixtures of those preparations only, so no preparation exception is printed for oxycodone. The Dangerous Drugs (Amendment) Act 2025 (Act 9 of 2025) does not amend Schedule 2. The model is a schedule printed in the Act, with a power in section 13(2) for the Minister to modify Schedule 2 by order. No order is printed in the 2022 Revised Edition and none appears beneath the Act on the legislation site's index, as read on 7 October 2026.

  Dangerous Drugs Act, Cap. 10.10, 2022 Revised Edition, sections 2, 5, 8, 13 to 16, 19, 20, 22, 25, 27, 30, 35, 39 and Schedule 2 Parts I and II (pages 32 to 35), read on 7 October 2026, sha256 c9e514235adcb847c794d886eb122ee2962045e6ea0e7c9ccaba18526a1cd53e · tuvalu-legislation.tv · Dangerous Drugs (Amendment) Act 2025, Act 9 of 2025, sections 1 to 6 and Schedule 3 (pages 5 to 9), read on 7 October 2026, sha256 36ac0ea5a9d1955f1967d00431c2a9e3cd94947e715f3881270ec4f2756863e6 · tuvalu-legislation.tv · Pharmacy and Therapeutic Products Act, Cap. 28.32, 2022 Revised Edition, sections 4, 9 and 42, read on 7 October 2026, sha256 625b92971e321cb4409bfbe2ce561a8674fa3a7e489afc00254a22e139dd3021 · tuvalu-legislation.tv · Customs Revenue and Border Protection Act 2014, Cap. 26.04, 2022 Revised Edition, sections 78, 212, 215, 216 and Schedule 2, printed pages 47, 108 to 110 and 145 to 147, read on 7 October 2026, sha256 b1747fd3511bcd3111d35f699933d9de68137065643d8bcf6f09d79b4778fbc0 · tuvalu-legislation.tv · Tuvalu Legislation On-line home page, read on 7 October 2026 · tuvalu-legislation.tv · Verified October 7, 2026